Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

BUY
$434.7 - $599.3 $69,986 - $96,487
161 Added 5.09%
3,327 $1.79 Million
Q2 2023

Jul 28, 2023

BUY
$350.74 - $468.98 $1.11 Million - $1.48 Million
3,166 New
3,166 $1.48 Million
Q4 2022

Feb 03, 2023

SELL
$321.55 - $374.67 $46,624 - $54,327
-145 Reduced 1.91%
7,435 $2.72 Million
Q3 2022

Oct 28, 2022

SELL
$296.48 - $337.87 $182,335 - $207,790
-615 Reduced 7.5%
7,580 $2.45 Million
Q2 2022

Aug 04, 2022

BUY
$278.73 - $327.27 $312,456 - $366,869
1,121 Added 15.85%
8,195 $2.66 Million
Q1 2022

Apr 26, 2022

BUY
$234.69 - $291.66 $1.66 Million - $2.06 Million
7,074 New
7,074 $2.03 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $771B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Efg Asset Management (North America) Corp. Portfolio

Follow Efg Asset Management (North America) Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (North America) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (North America) Corp. with notifications on news.